Fellowship in Pediatric Blood and Marrow Transplantation
The world’s first successful bone marrow transplant was performed in 1968 at the University of Minnesotan in a child with severe combined immunodeficiency syndrome. Since that time, the Blood and Marrow Program at the University of Minnesota has been a leader in the field of blood and marrow transplantation. Driven to find new treatments and safer transplant therapies for children with life threatening malignant and non malignant diseases, University of Minnesota investigators have received millions of dollars in NIH and industry support to manipulate the immune system to kill cancer cells and harness the power of stem cells to repair diseased or chemotherapy and radiation damaged tissues. The University of Minnesota Pediatric Blood and Marrow Transplant Fellowship provides Board Eligible or Board Certified Pediatric Hematologists/Oncologists with a clinical and research training experience of exceptional breadth and depth in blood and marrow transplantation. Our internationally-recognized Pediatric BMT Center serves children from throughout the United States and abroad who are undergoing allogeneic transplant for diverse primary disorders (including high-risk hemato-lymphoid malignancies, primary immune deficiencies, non-malignant hematologic disorders, acquired and inherited marrow failures, metabolic disorders, and life-threatening forms of epidermolysis bullosa) as well as autologous stem cell rescue following high-dose chemotherapy for high-risk pedaitric solid tumors. The pediatric BMT fellow will gain expertise in determining patient candidacy for BMT, assigning ideal conditioning regimens, selecting appropriate allograft source, and managing common peri- and post-transplant complications in both the inpatient and outpatient clinical setting. The successful applicant will benefit greatly from a large pediatric BMT faculty (n=18) with diverse clinical and research interests, high patient volumes, exposure to novel cell- and immune-based therapeutic strategies, and a close collaboration with an internationally-recognized Adult BMT Center and cell processing cGMP facility. Our one year program is designed to provide enough structure to ensure a well-rounded training experience while allowing for flexibility to address the specific goals of the fellow. Ultimately, our program is committed to continuing its tradition of training leaders and innovators worldwide who will help to shape the future of Pediatric Blood and Marrow Transplantation. Conference Schedules (click here for a calendar of events) Monday
7:30 to 8:30am Hematopathology (2nd and 4th Monday)
1 to 2pm Neuro-Oncology Tumor Board
1:15 to 2:15pm BMT Research Conference Tuesday
7:30 to 8:30am Journal Club (monthly)
Noon to 1pm Cancer Center Seminar Wednesday
12:15 to 1:15pm Pediatric Grand Rounds
3:30 to 4:15pm Hem/Onc Tumor Conference
4:15 to 5:00pm Fellow’s Core Lecture Thursday
7 to 8am Bone & Soft Tissue Sarcoma Tumor Board Friday
Noon to 1pm Pediatric Morbidity/Mortality/Management
2:00 to 3:00pm Hem/Onc/BMT Patient Rounds In total, the BMT fellow will spend half of his or her year among the BMT inpatient and outpatient services (3 months of each)with the remaining 6 months spent participating in research activities with BMT faculty.. Application, Interview, Selection Process
Interested applicants should submit a universal application, current curriculum vitae, personal statement, USMLE Score Reports (Step I and II) and three letters of recommendation (MD/PhD applicants must include a letter from their thesis advisor). Letters should be addressed to Dr. Angela Smith at the University of Minnesota and mailed by the letter writer directly to: Valerie B. Cole, Fellowship Coordinator
Pediatrics Education Office - Amplatz Children's Hospital
1st Floor East Building
8950A (Campus Delivery Code)
2450 Riverside Ave
Minneapolis, MN 55455
phone: 612-624-8788
Letters may also be faxed to Ms. Valerie Cole at 612-626-7042 or emailed.
|
